NEW YORK—Satraplatin, the first oral platinum analogue, is among the more promising second-line treatments for hormone-refractory prostate cancer (HRPC), a researcher said here at the 2006 Chemotherapy Foundation Symposium.
SAN DIEGO—No baseline transferrin saturation (TSAT), serum ferritin, or soluble transferrin receptor value predicts how hemodialysis patients with high ferritin levels will respond to IV iron therapy.
Systemic nitric oxide (NO) levels are elevated in patients with proliferative lupus nephritis, researchers found. The association is independent of renal elimination of nitrate and nitrite (NOx), a measure of NO production.
Older age, acute MI, and hypotension are among the factors that predict ICU mortality among patients with acute renal failure (ARF), data show.
Prostate growth in men with benign prostatic hyperplasia (BPH) is increased in the presence of the metabolic syndrome, according to a study that supports a causative role for hyperinsulinemia.
Rituximab (Rituxan), a biologic agent used to treat B-cell non-Hodgkin’s lymphoma, may offer a promising option for treating severe membranous lupus nephritis (MLN), according to Swedish researchers.
Ureteroscopic pneumatic lithotripsy (URS-PL) has a high success rate in treating unilateral distal-ureteral stones, a study found.
After decades of controversy, the verdict is in: Low-carbohydrate, higher-fat diets do not increase women’s risk of CHD. But the source of fat matters: It should be vegetable instead of animal.
When Dr. R, age 33, finished his urologic residency and went in search of a location to settle down, he selected a community hospital in a rural area. He was attracted because the hospital already had two urologists on the staff, and he was assured by the hospital administrator that the ER call was on a rotating basis.
CHICAGO—Two studies suggest that physicians need to pay attention to renal insufficiency in hospitalized patients with cardiac conditions.
